[Practical experience of endotelon application in patients with cervix uteri cancer after extended panhysterectomy]

Dolyk Ss, S S Dolyk
Klinichna khirurhiia · 2004 · pp. 38–9 · PMID:15369303 · W2414657931
Non-randomised trial OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-11 ⓘ

Application of endotelon in early postoperative periods for stage I-II cervical cancer patients following extended panhysterectomy reduces the frequency of retroperitoneal lymphatic cysts and lower extremity lymphostasis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Application of endotelon in early period after extended panhysterectomy in patients with cervix uteri cancer of I-II stages promotes reduction of the occurrence frequency of retroperitoneal lymphatic cyst and lymphostasis in parametrium and lower extremities.

My notes (saved in your browser only)

MeSH descriptors

Biflavonoids Catechin Hysterectomy Hysterectomy Proanthocyanidins Uterine Neoplasms Uterine Neoplasms Biflavonoids Catechin Female Humans Hysterectomy Neoplasm Staging Postoperative Period Proanthocyanidins Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:02:42.299833+00:00
License: CC0 · commercial use OK